These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28029750)

  • 21. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2007 Sep; 15(9):981-1000. PubMed ID: 17719803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis.
    Fleischmann R; Furst DE
    Expert Opin Drug Saf; 2020 Aug; 19(8):935-944. PubMed ID: 32497440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glucocorticoids on radiological progression in rheumatoid arthritis.
    Kirwan JR; Bijlsma JW; Boers M; Shea BJ
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD006356. PubMed ID: 17253590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of assessment and management of morning stiffness in Asian patients with rheumatoid arthritis: Recommendations from an expert panel.
    Mok CC; Cha HS; Hidayat R; Nguyen LT; Perez EC; Ramachandran R; Tsay GJ; Yoo DH;
    Int J Rheum Dis; 2016 Jan; 19(1):30-7. PubMed ID: 26403254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids.
    George MD; Baker JF; Wallace B; Chen L; Wu Q; Xie F; Yun H; Curtis JR
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1597-1605. PubMed ID: 32702188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years.
    Santiago T; da Silva JA
    Ann N Y Acad Sci; 2014 May; 1318():41-9. PubMed ID: 24814757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review.
    Sanmartí R; Tornero J; Narváez J; Muñoz A; Garmendia E; Ortiz AM; Abad MA; Moya P; Mateo ML; Reina D; Salvatierra-Ossorio J; Rodriguez S; Palmou-Fontana N; Ruibal-Escribano A; Calvo-Alén J
    Reumatol Clin (Engl Ed); 2020; 16(3):222-228. PubMed ID: 30057295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of glucocorticoids in rheumatoid arthritis - pratical modalities of glucocorticoid therapy: recommendations for clinical practice based on data from the literature and expert opinion.
    Dernis E; Ruyssen-Witrand A; Mouterde G; Maillefert JF; Tebib J; Cantagrel A; Claudepierre P; Fautrel B; Gaudin P; Pham T; Schaeverbeke T; Wendling D; Saraux A; Loët XL
    Joint Bone Spine; 2010 Oct; 77(5):451-7. PubMed ID: 20471886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity.
    Doumen M; Pazmino S; Bertrand D; Westhovens R; Verschueren P
    Joint Bone Spine; 2023 May; 90(3):105491. PubMed ID: 36410680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.
    Hartman L; Rasch LA; Klausch T; Bijlsma HWJ; Christensen R; Smulders YM; Ralston SH; Buttgereit F; Cutolo M; Da Silva JAP; Opris D; Rovenský J; Szamosi S; Middelink LM; Lems WF; Boers M
    Trials; 2018 Jan; 19(1):67. PubMed ID: 29370811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Cancer.
    Lopez-Olivo MA; Colmegna I; Karpes Matusevich AR; Qi SR; Zamora NV; Sharma R; Pratt G; Suarez-Almazor ME
    Arthritis Care Res (Hoboken); 2020 Mar; 72(3):309-318. PubMed ID: 30821928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis.
    Xie W; Yang X; Ji L; Zhang Z
    Semin Arthritis Rheum; 2020 Aug; 50(4):598-607. PubMed ID: 32480098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis].
    Chinese Rheumatology Association
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):242-251. PubMed ID: 29614581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.
    Lau CS; Chia F; Dans L; Harrison A; Hsieh TY; Jain R; Jung SM; Kishimoto M; Kumar A; Leong KP; Li Z; Lichauco JJ; Louthrenoo W; Luo SF; Mu R; Nash P; Ng CT; Suryana B; Wijaya LK; Yeap SS
    Int J Rheum Dis; 2019 Mar; 22(3):357-375. PubMed ID: 30809944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prednisone for rheumatoid arthritis: the detriment of the doubt].
    Boers M
    Ned Tijdschr Geneeskd; 2012; 155(32):A5069. PubMed ID: 22871244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid and opioid use in rheumatoid arthritis management.
    Moore MN; Wallace BI
    Curr Opin Rheumatol; 2021 May; 33(3):277-283. PubMed ID: 33625045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.